Reported resultsCompany-reported
What was reported
HUDSON, MA, and YOKNEAM ILLIT, Israel, May 15, 2026 – Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a diversified biomedical innovation company with a portfolio of commercialized neurorehabilitation products and a biomedical pipeline, today announced its financial results for the first quarter ended March 31, 2026 and that it will delay filing of its Form 10-Q for the quarter ended March 31, 2026 as additional time is needed to finalize the accounting and financial reporting related to the strategic transaction completed in March 2026.U.S. Securities and Exchange Commission (EDGAR) · Exhibit 99.1 to 8-K · May 15, 2026 · Open the source ↗
What the evidence supports
Lifeward published its results for the period in a press release furnished to the SEC (Form 8-K, Item 2.02).
What remains unknown
Audit status of the figures (results furnished on Form 8-K or 6-K are typically unaudited), and anything about future periods. Any outlook is the company's own projection. Figures and claims are the company's own description and have not been independently verified.
Figures as stated
Numbers exactly as written in the source. We don’t annualise, convert or add them up.
| Figure | In context |
|---|---|
| $10 million | “• Strategic transaction closed with equity-based acquisition of Oratech: $10 million financing received” Mentions: acquisition, financing |
Source passages
Exact excerpts from the source, with links. Quotes are checked character for character against our stored copy.
Press release headlineLifeward Reports First Quarter 2026 Financial ResultsU.S. Securities and Exchange Commission (EDGAR) · Exhibit 99.1 to 8-K · May 15, 2026 · Open the source ↗
Press release lead paragraphHUDSON, MA, and YOKNEAM ILLIT, Israel, May 15, 2026 – Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a diversified biomedical innovation company with a portfolio of commercialized neurorehabilitation products and a biomedical pipeline, today announced its financial results for the first quarter ended March 31, 2026 and that it will delay filing of its Form 10-Q for the quarter ended March 31, 2026 as additional time is needed to finalize the accounting and financial reporting related to the strategic transaction completed in March 2026.U.S. Securities and Exchange Commission (EDGAR) · Exhibit 99.1 to 8-K · May 15, 2026 · Open the source ↗
Amount stated in press release• Strategic transaction closed with equity-based acquisition of Oratech: $10 million financing receivedU.S. Securities and Exchange Commission (EDGAR) · Exhibit 99.1 to 8-K · May 15, 2026 · Open the source ↗
Revision history
- Revision 1 · Oct 28, 2026, 20:51 UTC
Lifeward Reports First Quarter 2026 Financial Results
Spotted an error? Tell us. Corrections are published, never silent: see all corrections.